Top

Pediatric Cardiology

Published in:

25-04-2022 | Letter to the Editor

Towards Reference Values for NT-proBNP Applicable in Pediatric Clinical Practice

Authors: Moisés Rodríguez-González, Ana Castellano-Martínez

Published in: Pediatric Cardiology | Issue 6/2022

Excerpt

Dear Editor, …

Kiess A, Green J, Willenberg A, Ceglarek U, Dähnert I, Jurkutat A, Körner A, Hiemisch A, Kiess W, Vogel M (2022) Age-dependent reference values for hs-Troponin T and NT-proBNP and determining factors in a cohort of healthy children (The LIFE Child Study). Pediatr Cardiol. https://doi.org/10.1007/s00246-022-02827-xCrossRefPubMedPubMedCentral

Palm J, Hoffmann G, Klawonn F, Tutarel O, Palm H, Holdenrieder S, Ewert P (2020) Continuous, complete and comparable NT-proBNP reference ranges in healthy children. Clin Chem Lab Med 58:1509–1516. https://doi.org/10.1515/cclm-2019-1185CrossRefPubMed

Palm J, Holdenrieder S, Hoffmann G, Hörer J, Shi R, Klawonn F, Ewert P (2021) Predicting major adverse cardiovascular events in children with age-adjusted NT-proBNP. J Am Coll Cardiol 78:1890–1900CrossRef

Müller N, Rothkegel ST, Boerter N, Sumaria K, Breuer J, Freudenthal NJ (2021) Perioperative urinary NT-ProBNP values and their usefulness as diagnostic and prognostic markers in children with congenital heart disease. Clin Chim Acta 518:28–32CrossRef

Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS (2009) NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 30:3–8. https://doi.org/10.1007/s00246-008-9258-4CrossRefPubMed

Title: Towards Reference Values for NT-proBNP Applicable in Pediatric Clinical Practice
Authors: Moisés Rodríguez-González
Ana Castellano-Martínez
Publication date: 25-04-2022
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 6/2022
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-022-02910-3

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Towards Reference Values for NT-proBNP Applicable in Pediatric Clinical Practice

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2022

Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Kawasaki Disease Arab Initiative [Kawarabi]: Establishment and Results of a Multicenter Survey

CMR Imaging After Myocarditis Associated with mRNA COVID-19 Vaccine: Correspondence

Upcoming Events in Pediatric Cardiology

Comparison of Strain-Encoding and Feature-Tracking Derived Myocardial Deformation Assessment of Left Ventricular Function in a Pediatric and Adult Congenital Heart Disease Cohort

Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page